Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis

Leflunomide inhibits nitric oxide production in patients with active RA. Inhibition of NO synthesis may be one of the mechanisms responsible for the immunomodulatory activity of leflunomide.